AML/MDS

Clinical trials for AML/MDS explained in plain language.

Never miss a new study

Get alerted when new AML/MDS trials appear

Sign up with your email to follow new studies for AML/MDS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1 Completed 1

New pill tested for tough blood cancers after other treatments fail

Disease control Completed

This early-stage study tested a new oral drug called LP-108, given alone or with another cancer drug (azacitidine), in adults with advanced blood cancers that had returned or did not respond to prior treatments. The main goals were to find a safe dose, see how the body processes …

Matched conditions: AML/MDS

Phase: PHASE1 • Sponsor: Newave Pharmaceutical Inc • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

AML/MDS

Get alerted when new AML/MDS trials appear

New pill tested for tough blood cancers after other treatments fail